What Are Wall Street Analysts' Target Price for Eli Lilly Stock?

With a market cap of $799.5 billion, Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading global pharmaceutical firm renowned for its innovative contributions to healthcare. The company has developed notable medications such as Prozac for depression, Humalog for diabetes, and Mounjaro for type 2 diabetes.

Shares of the drugmaker have outperformed the broader market over the past 52 weeks. LLY has increased 24.6% over this time frame, while the broader S&P 500 Index ($SPX) has gained 22.6%. In addition, LLY stock has risen 13.8% on a YTD basis, compared to SPX's 3.3% YTD gain.